Valeant Pharmaceuticals Intl Company Profile (TSE:VRX)

About Valeant Pharmaceuticals Intl

Valeant Pharmaceuticals Intl logoValeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, CeraVe, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: VRX
  • CUSIP:
Key Metrics:
  • Previous Close: $21.20
  • 50 Day Moving Average: $19.74
  • 200 Day Moving Average: $26.51
  • 52-Week Range: C$347,669,000.00 - C$17.19
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.20
  • Market Cap: $7.37B
  • Outstanding Shares: 347,669,000
Additional Links:

Analyst Ratings

Consensus Ratings for Valeant Pharmaceuticals Intl (TSE:VRX) (?)
Ratings Breakdown: 4 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: C$23.83

Analysts' Ratings History for Valeant Pharmaceuticals Intl (TSE:VRX)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2017TD SecuritiesReiterated RatingHoldC$18.50View Rating Details
2/17/2017ScotiabankLower Price TargetSector PerformC$17.00 -> C$15.00View Rating Details
2/6/2017Royal Bank of CanadaReiterated RatingSector PerformC$38.00View Rating Details
12/15/2016Morgan StanleyDowngradeOverweight -> Equal WeightView Rating Details
11/19/2015Citigroup Inc.Reiterated RatingOverweightView Rating Details
11/2/2015Goldman Sachs Group, Inc. (The)DowngradeBuy -> NeutralView Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Valeant Pharmaceuticals Intl (TSE:VRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2017$1.21N/AView Earnings Details
5/9/2014$1.83$1.90ViewN/AView Earnings Details
8/7/20132Q13$0.03ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Valeant Pharmaceuticals Intl (TSE:VRX)
Current Year EPS Consensus Estimate: $5.43 EPS

Dividends

Dividend History for Valeant Pharmaceuticals Intl (TSE:VRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Valeant Pharmaceuticals Intl (TSE:VRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/5/2015J. Michael PearsonDirectorSell350,000C$0.00C$0.00
10/21/2015Ron FarmerDirectorBuy1,000C$193.00C$193,000.00
5/26/2015Whitaker AnneInsiderBuy2,500C$234.00C$585,000.00
5/4/2015Robert Roswell Chai-OnnInsiderSell90,938C$222.54C$20,237,433.46
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Valeant Pharmaceuticals Intl (TSE:VRX)
DateHeadline
blogs.barrons.com logoValeant's Ugly Earnings History May Repeat Itself (TSE:VRX)
blogs.barrons.com - February 25 at 4:18 AM
finance.yahoo.com logoSequoia Fund wins dismissal of lawsuit over huge Valeant stake (TSE:VRX)
finance.yahoo.com - February 25 at 4:18 AM
investorplace.com logoSiliq Won't Bring Valeant Pharmaceuticals Intl Inc (VRX) Stock Back to Life - Investorplace.com (TSE:VRX)
investorplace.com - February 24 at 9:14 AM
4-traders.com logoValeant Pharmaceuticals Intl : Former Valeant and Philidor executives plead not guilty in fraud scheme (TSE:VRX)
www.4-traders.com - February 23 at 11:47 PM
News IconAnalysts Are Circling Valeant Pharmaceuticals International, Inc. (NYSE:VRX): Where Do Research Brokers See It ... - Winfield Review (TSE:VRX)
winfieldreview.com - February 23 at 3:21 AM
seekingalpha.com logoPrice target range introduced: $20 - $34 a share. - Seeking Alpha (TSE:VRX)
seekingalpha.com - February 23 at 3:21 AM
finance.yahoo.com logoPRESS DIGEST- New York Times business news - Feb 23 (TSE:VRX)
finance.yahoo.com - February 23 at 3:21 AM
streetinsider.com logoValeant Pharma (VRX), EyeGate (EYEG) Enter Into Licensing Agreement For EGP-437 (TSE:VRX)
www.streetinsider.com - February 21 at 4:07 PM
rttnews.com logoEyeGate Pharmaceuticals Inc. (EYEG) Is Up Sharply On Valeant Agreement (TSE:VRX)
www.rttnews.com - February 21 at 4:07 PM
News IconValeant deal with EyeGate bolsters B&L offerings (TSE:VRX)
www.rbj.net - February 21 at 4:07 PM
smarteranalyst.com logoValeant Pharmaceuticals Intl Inc (VRX): Will Psoriasis Drug Siliq Turn The Tide For The Giant? (TSE:VRX)
www.smarteranalyst.com - February 21 at 4:07 PM
finance.yahoo.com logoValeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In … (TSE:VRX)
finance.yahoo.com - February 21 at 8:14 AM
ft.com logo[$$] Unilever was a deal too far for Kraft Heinz (TSE:VRX)
www.ft.com - February 20 at 7:33 PM
finance.yahoo.com logoThis Guru Loves Valeant; Should You? (TSE:VRX)
finance.yahoo.com - February 20 at 7:33 PM
News IconCutting Valeant Pharmaceuticals Intl Inc' (NYSE:VRX) brodalumab Sales Forecast Due to Onerous REMS - Smаrt Stоck Nеws (TSE:VRX)
www.smartstocknews.com - February 18 at 11:23 AM
investorplace.com logoWhy Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Still in Trouble - Investorplace.com (TSE:VRX)
investorplace.com - February 17 at 5:06 PM
seekingalpha.com logoValeant: Brodalumab Approval Won't End Woes - Seeking Alpha (TSE:VRX)
seekingalpha.com - February 17 at 6:59 AM
News IconJack Dorsey Loves Twitter (TWTR); Valeant Pharmaceuticals Intl (VRX) Defies Headwinds (TSE:VRX)
galaxystocks.com - February 15 at 1:52 AM
News IconRevenue Growth Analysis of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSE:VRX)
ibusinesslines.com - February 14 at 8:52 PM
News IconStifel Nicolaus Reiterates Buy Rating for Valeant Pharmaceuticals International, Inc. (VRX) (TSE:VRX)
www.graffiotech.com - February 14 at 8:52 PM
investorplace.com logoValeant Pharmaceuticals Intl Inc (VRX) Stock Is Worse Off Than You Think - Investorplace.com (TSE:VRX)
investorplace.com - February 14 at 3:50 PM
seekingalpha.com logoValeant: A Major Run Is Underway - Seeking Alpha (TSE:VRX)
seekingalpha.com - February 14 at 6:58 AM
finance.yahoo.com logoValeant Pharmaceuticals To Participate At Healthcare Conferences (TSE:VRX)
finance.yahoo.com - February 14 at 6:58 AM
News IconBarclays Just Issued “Equal Weight” Rating on Valeant Pharmaceuticals Intl Inc (VRX) - Highland Mirror (TSE:VRX)
www.highlandmirror.com - February 12 at 11:42 PM
capitalcube.com logoValeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-CA : February 10, 2017 (TSE:VRX)
www.capitalcube.com - February 11 at 6:15 AM
blogs.barrons.com logoValeant Pharmaceutcials: I Guess That's Why They Call It 'Equal Weight' (TSE:VRX)
blogs.barrons.com - February 11 at 6:15 AM
investorplace.com logoValeant Pharmaceuticals Intl Inc (VRX) Stock Is Due for More ... - Investorplace.com (TSE:VRX)
investorplace.com - February 10 at 6:33 AM
fool.com logoThe Important Lesson We Can All Learn From Valeant Pharmaceuticals (TSE:VRX)
www.fool.com - February 10 at 6:33 AM
streetinsider.com logoFTC Approves Final Order with Valeant (VRX) Regarding Acquisition of Paragon Holdings (TSE:VRX)
www.streetinsider.com - February 9 at 6:36 AM
marketrealist.com logoWhat Bill Miller Thinks about Valeant Pharmaceuticals (TSE:VRX)
marketrealist.com - February 9 at 6:35 AM
blogs.barrons.com logoValeant: Another Analyst Cuts Target, Stays Buy Rated Into Earnings (TSE:VRX)
blogs.barrons.com - February 9 at 6:35 AM
bloomberg.com logoThe World According to a Free-Range Short Seller With Nothing to Lose (TSE:VRX)
www.bloomberg.com - February 9 at 6:35 AM
smarteranalyst.com logoWhat to Look for When Valeant Pharmaceuticals Intl Inc (VRX) Reports Earnings (TSE:VRX)
www.smarteranalyst.com - February 7 at 8:38 PM
investorplace.com logoShould I Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons - Investorplace.com (TSE:VRX)
investorplace.com - February 7 at 3:37 PM
seekingalpha.com logoValeant Is Selling Itself Short (TSE:VRX)
seekingalpha.com - February 7 at 2:33 AM
blogs.barrons.com logoValeant Pharmaceuticals: Why This Earnings Report is Really, Really Important (TSE:VRX)
blogs.barrons.com - February 7 at 2:33 AM
News IconPast Quarters Surprise Report for Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSE:VRX)
cote-ivoire.com - February 4 at 6:11 AM
News IconHere's Valeant Pharmaceuticals Intl Inc (VRX) Stock Update (TSE:VRX)
xboxonezone.com - February 4 at 6:11 AM
bloomberg.com logoValeant Short Seller Picks Next Target (TSE:VRX)
www.bloomberg.com - February 3 at 6:40 AM
investorplace.com logoValeant Pharmaceuticals Intl Inc (VRX) Has Only a Little Time Left - Investorplace.com (TSE:VRX)
investorplace.com - February 2 at 6:40 AM
News IconDaily Ratings & News for Valeant Pharmaceuticals International Inc (TSE:VRX)
xboxonezone.com - February 1 at 7:20 AM
News IconPT Review for Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Shares (TSE:VRX)
perspectivabetica.com - February 1 at 7:20 AM
4-traders.com logoValeant Pharmaceuticals Intl : To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance (TSE:VRX)
www.4-traders.com - January 30 at 9:15 PM
finance.yahoo.com logoValeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance (TSE:VRX)
finance.yahoo.com - January 30 at 9:14 PM
News IconIs There Inherent Value in Valeant Pharmaceuticals International, Inc. (NYSE:VRX)? Analysts Delve Into The Stock - Wall Street Beacon (TSE:VRX)
wsbeacon.com - January 30 at 9:59 AM
finance.yahoo.com logoWill Valeant Pharmaceuticals Intl Inc. Survive the Trump Presidency? (TSE:VRX)
ca.finance.yahoo.com - January 29 at 5:16 AM
finance.yahoo.com logoHow 2017 Will Unfold for Valeant Pharmaceuticals Intl Inc. (TSE:VRX)
ca.finance.yahoo.com - January 28 at 2:01 AM
finance.yahoo.com logoPershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance (TSE:VRX)
finance.yahoo.com - January 27 at 9:00 PM
smarteranalyst.com logoInvest Like John Paulson: Valeant Pharmaceuticals Intl Inc (VRX), Synergy Pharmaceuticals Inc (SGYP), Endo ... - Smarter Analyst (TSE:VRX)
www.smarteranalyst.com - January 25 at 9:30 PM
nasdaq.com logoShould You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons - Nasdaq (TSE:VRX)
www.nasdaq.com - January 24 at 3:24 PM

Social

What is Valeant Pharmaceuticals Intl's stock symbol?

Valeant Pharmaceuticals Intl trades on the Tornton Stock Exchange (TSX) under the ticker symbol "VRX."

Where is Valeant Pharmaceuticals Intl's stock going? Where will Valeant Pharmaceuticals Intl's stock price be in 2017?

4 brokers have issued twelve-month target prices for Valeant Pharmaceuticals Intl's shares. Their forecasts range from C$15.00 to C$38.00. On average, they expect Valeant Pharmaceuticals Intl's stock price to reach C$23.83 in the next twelve months.

When will Valeant Pharmaceuticals Intl announce their earnings?

Valeant Pharmaceuticals Intl is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

How do I buy Valeant Pharmaceuticals Intl stock?

Shares of Valeant Pharmaceuticals Intl and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How much does a share of Valeant Pharmaceuticals Intl stock cost?

One share of Valeant Pharmaceuticals Intl stock can currently be purchased for approximately C$21.20.

Valeant Pharmaceuticals Intl (TSE:VRX) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Valeant Pharmaceuticals Intl (TSE:VRX)

Earnings History Chart

Earnings by Quarter for Valeant Pharmaceuticals Intl (TSE:VRX)

Dividend History Chart

Dividend Payments by Quarter for Valeant Pharmaceuticals Intl (TSE:VRX)

Last Updated on 2/26/2017 by MarketBeat.com Staff